Home Neoplasma 2018 Neoplasma Vol.65, No.3, p.441-448, 2018

Journal info


6 times a year.
Founded: 1954
ISSN 0028-2685
ISSN 1338-4317 (online)

Published in English

Editorial Info
Abstracted and Indexed
Submission Guidelines

Select Journal







Webshop Cart

Your Cart is currently empty.

Info: Your browser does not accept cookies. To put products into your cart and purchase them you need to enable cookies.

Neoplasma Vol.65, No.3, p.441-448, 2018

Title: HPV status and its genomic integration affect survival of patients with cervical cancer
Author: M. IBRAGIMOVA, M. TSYGANOV, O. SHPILEVA, O. CHURUKSAEVA, V. BYCHKOV, L. KOLOMIETS, N. LITVIAKOV

Abstract: The aim of this study is the evaluation of relapse-free and overall survival of HPV-positive patients with regard to the physical status of type 16 HPV and of HPV-negative patients with primary cervical cancer. As a main result of the study, the predictive value of the physical status of type 16 HPV was determined for relapse-free and overall survival of patients with cervical cancer. Episomal form of the virus is a favorable predictive factor. Integrated form of the virus is a severely unfavor- able predictive factor and survival of such patients is significantly lower than of HPV-patients and patients with mixed form of the virus. The results of the research are data on survival of patients with cervical cancer depending on the physical status of the virus (for HPV+ patients) and of patients with HPV-negative cancer.

Keywords: HPV, genomic integration, cervical cancer
Published online: 16-May-2018
Year: 2018, Volume: 65, Issue: 3 Page From: 441, Page To: 448
doi:10.4149/neo_2018_170414N277
Price: 19.20 €






© AEPress s.r.o
Copyright notice: For any permission to reproduce, archive or otherwise use the documents in the ELiS, please contact AEP.